VTVT
vTv Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$24.83
−5.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.25x
- Price / sales
- 2.66x
- Price / cash flow
- -5.86x
Enterprise value
- Enterprise value
- $11.5M
- EV / sales
- 0.31x
- EV / EBITDA
- -1.80x
- EV / EBIT
- -1.24x
- Market cap
- $98.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026